Volker Huppert

Chief Development Officer at Glycostem Therapeutics

Speaker

Volker is a passionate cell therapy product developer and manufacturer with 30 years experience in the industry. He is a bioprocess engineer from Aachen Technical University by training. He is Chief Development Officer at Glycostem Therapeutics B.V., a clinical stage biotech company in the Netherlands, leading the activities for process development and manufacturing of a cord blood stem cell derived NK cell product, a successfully clinically evaluated (phase I) universal, off-the-shelf product candidate He has previously pioneered clinical grade processing of Hematopoetic Stem Cells and Natural Killer cells in closed, automated manufacturing sytems with Miltenyi Biotec, including cell separation, cell culture, transduction and analysis. Volker has been instrumental in bringing the first applications of the CliniMACS Prodigy device to the market, providing a platform for a variety of cell therapy applications.